Massimino D'Armiento Selected Research

Massimino D'Armiento Research Topics

Disease

11	Neoplasms (Cancer) 05/2016 - 02/2007
7	Thyroid Neoplasms (Thyroid Cancer) 05/2016 - 07/2006
4	Pain (Aches) 02/2007 - 01/2003
3	Papillary Thyroid Cancer 01/2015 - 02/2011
3	Anaplastic Thyroid Carcinoma 10/2014 - 06/2008
3	Prostatic Neoplasms (Prostate Cancer) 02/2007 - 01/2003
2	Genomic Instability 05/2016 - 02/2010
1	Melanoma (Melanoma, Malignant) 01/2015
1	Ovarian Neoplasms (Ovarian Cancer) 01/2015
1	Hematologic Neoplasms (Hematological Malignancy) 01/2015
1	Necrosis 10/2014
1	Breast Neoplasms (Breast Cancer) 01/2014
1	Aneuploidy (Aneuploid) 01/2014
1	Chromosomal Instability (Chromosome Stability) 01/2014
1	Hypothyroidism 06/2013
1	Seminoma 04/2010
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2010
1	Thyroid Diseases (Thyroid Disease) 01/2010
1	Neoplasm Metastasis (Metastasis) 02/2009
1	Carcinoma (Carcinomatosis) 12/2006
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2006
1	Kidney Neoplasms (Kidney Cancer) 12/2006
1	Papillary Carcinoma 07/2006
1	Adenoma (Adenomas) 07/2006
1	Postoperative Pain 04/2005
1	Wounds and Injuries (Trauma) 04/2005

Drug/Important Bio-Agent (IBA)

8	Aurora KinasesIBA 05/2016 - 07/2006
4	Messenger RNA (mRNA)IBA 01/2015 - 07/2006
4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2012 - 02/2009
4	Plasminogen Activators (Plasminogen Activator)IBA 11/2012 - 02/2009
4	Proteins (Proteins, Gene)FDA Link 09/2011 - 07/2006
3	AutoantibodiesIBA 01/2015 - 01/2010
3	Plasminogen Activator Inhibitor 1IBA 02/2011 - 02/2009
3	PlasminogenIBA 02/2011 - 02/2009
3	Analgesics (Analgesic Drugs)IBA 02/2007 - 01/2003
3	Hormones (Hormone)IBA 02/2007 - 01/2003
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 01/2014
2	Phosphotransferases (Kinase)IBA 01/2014 - 07/2006
2	Urokinase Plasminogen Activator ReceptorsIBA 02/2011 - 04/2010
2	Aurora Kinase AIBA 02/2010 - 09/2007
1	MLN 8237IBA 10/2014
1	2- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA 10/2014
1	Biological ProductsIBA 01/2014
1	Thyroglobulin FDA Link 01/2014
1	Thyroxine (Levothyroxine)FDA LinkGeneric 06/2013
1	Plasminogen Activator Inhibitor 2IBA 04/2010
1	Tissue ExtractsIBA 04/2010
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2010
1	AntigensIBA 01/2010
1	Peptides (Polypeptides)IBA 02/2009
1	Fibrinolysin FDA Link 02/2009
1	Enzyme Precursors (Zymogens)IBA 02/2009
1	Serine Proteases (Serine Protease)IBA 02/2009
1	Monoclonal AntibodiesIBA 02/2009
1	tozasertibIBA 06/2008
1	Prednisone (Sone)FDA LinkGeneric 02/2007
1	Pharmaceutical PreparationsIBA 02/2007
1	Docetaxel (Taxotere)FDA Link 02/2007
1	Gemcitabine FDA Link 02/2007
1	Prostate-Specific Antigen (Semenogelase)IBA 02/2007
1	Zoledronic Acid (Zometa)FDA Link 02/2007
1	Testosterone (Sustanon)FDA Link 01/2003
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2003

Therapy/Procedure

4	Therapeutics 01/2014 - 12/2006
3	Thyroidectomy 05/2010 - 04/2005
3	Drug Therapy (Chemotherapy) 12/2006 - 01/2003
2	Minimally Invasive Surgical Procedures 05/2010 - 04/2005
1	Length of Stay 04/2005